Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2002-09-13
2008-03-25
Ewoldt, G. R. (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C530S356000
Reexamination Certificate
active
07348005
ABSTRACT:
The present invention relates to the use of collagen and MHC-like compounds to down regulate immune responses. Methods for administration of such compounds that induce immune tolerance are described. The invention is important in the context of allograft rejection, transplantation, graft rejection, pleural disease and immunotolerance.
REFERENCES:
patent: 5593698 (1997-01-01), Weiner et al.
patent: 5962025 (1999-10-01), Carbone et al.
Hausen, B., et al. Transplantation. Feb. 15, 1999;67(3):354-359.
Mares, D.C., et al. Am J. Respir. Cell Mol. Biol. Jul. 2000;23:62-70.
Chen et al., “Peripheral deletion of antigen-reactive T cells in oral tolerance,”Nature, 376:177-180, 1995.
Chen et al., “Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis,”Science, 265:1237-1240, 1994.
Chiang et al., “Type V(A-B) collagen induces platelet aggregation,”J. Lab. Clin. Med., 95:99-107, 1980.
Cremer et al., “Type XI collagen-induced arthritis in the Lewis rat: characterization of cellular and humoral immune responses to native types XI, V, and II collagen and constituent α-chains,”J. Immunol. 153:824-832, 1994.
Danzer et al., “Cytokine interactions in human mixed lymphocyte culture,”Transplantation, 57(11):1638-1642, 1994.
DeMeester et al., “The bimodal expression of tumor necrosis factor-α in association with rat lung reimplantation and allograft rejection,”J. Immunol., 150(6):2494-2505, 1993.
Faria and Weiner, “Oral tolerance: mechanisms and therapeutic applications,”Adv. Immunol., 73:153-264, 1999.
Felts et al., “Immunologic tolerance to collagen and glycosaminoglycan components of scleral allografts in humans,”J. of Periodontology, 52:603-608, 1981.
Garrovillo et al., “Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells,”Transplantation, 68:1827-1834, 1999.
Hancock et al., “Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation,”Transplantation, 55:1112-1118, 1993.
Hanson et al., “The human α2(XI) collagen gene (COL11A2) maps to the centrometric of the major histocompatibility complex on chromosome 6,”Genomics, 5:925-931, 1989.
Hirt et al., “Development of obliterative bronchiolitis after allogeneic rat lung transplantation: Implication of acute rejection and the time point of treatment,”J. Heart Lung Transplant., 18:542-548, 1999.
Huang et al., “Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model,”J. Clin. Invest., 105:173-181, 2000.
Ishido et al., “Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes,”Transplantation, 68:1377-1382, 1999.
Iyer et al., “Characterization and biologic significance of immunosuppressive peptide D2702.75-84(E α V) binding protein,”J. Biol. Chem., 273(5):2692-2697, 1998.
Joo et al., “T-cell mediated responses in a murine model of orthotopic corneal transplantation,”Invest. Ophthalmol. Vis. Sci., 36:1530-1540, 1995.
Josien et al., “Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance,”Transplantation, 66:887-893, 1998.
Kallio et al., “Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat,”J. Clin Invest., 100:2984-2994, 1997.
Konomi et al., “Localization of type V collagen and type IV collagen in human cornea, lung, and skin,”Am. J. Pathol., 116:417-426, 1984.
Krensky and Clayberger, “HLA-derived peptides as novel immunosuppressives,”Nephrol. Dial. Transplant., 12:865-878, 1997.
Lowry et al., “Immune mechanisms in organ allograft rejection. VI. Delayed-type hypersensitivity and lymphotoxin in experimental renal allograft rejection,”Transplantation., 40:183-188, 1985.
Madri and Furthmayr, “Collagen polymorphism in the lung,”Human Pathology, 11:353-366, 1980.
Madri and Furthmayr, “Isolation and tissue localization of type AB2 collagen from normal lung parenchyma,”Am. J. Pathol., 94:323-332, 1979.
Marck et al., “Lung transplantation in the rat. III. Functional studies in iso- and allografts,”J. Surgical Res., 35:149-158, 1983.
Mares et al., “Type V collagen modulates allogantigen-induced pathology and immunology in the lung,”Am. J. of Respir. Cell and Mol. Biol., 23:62-70, 2000.
Matsumura et al., “Assessment of pathological changes associated with chronic allograft rejection and tolerance in two experimental models of rat lung transplantation,”Transplantation., 59:1509-1517, 1995.
Morris and Bachinger, “Type XI collagen is a heterotrimer with the composition (1α,2α, 3α) retaining non-triple helical domains,”J. Biological Chem., 262:11345-11350, 1987.
Murphy et al., “Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis,”J. Clin. Invest., 103:859-867, 1999.
Nösner et al., “HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family,”J. Exp. Med., 183:339-348, 1996.
Oluwole et al., “Induction of transplantation intolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides,”Transplantation, 56(6):1523-1527, 1993.
Prop et al., “Lung allograft rejection in the rat. I. Accelerated rejection caused by graft lymphocytes,”Transplantation, 40:25-30, 1985.
Prop et al., “Lung allograft rejection in the rat. II. Specific immunological properties of lung grafts,”Transplantation, 40:126-131, 1985.
Regis et al., “Fas-ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance,”Transplantation, 66(7):887-893, 1993.
Sayagh et al., “Mechanisms of T cell recognition of alloantigen,”Transplantation, 57:(9)1295-1302, 1994.
Sayegh and Krensky, “Novel immunotherapeutic strategies using MHC derived peptides,”Kidney Int. Suppl.53:S13-20, 1996.
Sayegh et al., “Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen,”Transplantation, 53:163-166, 1992.
Sayegh et al., “Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat,”Proc. Natl. Acad. Sci.,89: 7762-7766, 1992.
Sekine et al., “Role of passenger leukocytes in allograft rejection—Effect of depletion donor alveolar Macrophages on the local production of TNF-alpha, T helper 1/Thelper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation,”J. Immunol., 159:4084-4093, 1997.
Seyer and Kang, Covalent structure of collagen: amino acid sequence of three cyanogen bromide-derived peptides from human alpha 1(V) collagen chain.Arch. Biochem. Biophys.271(11): 120-129, 1989.
SivaSai et al., “Indirect recognition of donar HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome,”Transplantation. 67(8):1094-1098, 1999.
Smith Jr, et al., “Interaction of proteoglycans with pericellular (1 α, 2 α, 3 α) collagens of cartilage,”J. Biol. Chem.,260:10761-10767, 1985.
Strober and Coffman, “Tolerance and immunity in the mucosal immune system,”Res. Immunol., 148:489-498, 1997.
Trulock, “Lung transplantation,”Am. J. Respir. Crit. Care Med., 155:789-818, 1997.
VanBuskirk et al., “Patterns of allosensitization in allograft recipients: long-term allograft acceptance is associated
Advanced Research and Technology Institute
Ewoldt G. R.
Fulbright & Jaworski L.L.P.
LandOfFree
Oral tolerance induction by collagen to prevent allograft... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral tolerance induction by collagen to prevent allograft..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral tolerance induction by collagen to prevent allograft... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3965261